In their study, Cannon and his team collected data on 1,825 patients who were taking statins after having a heart attack or unstable angina. Patients were taking 80 milligrams daily of the drug brand-named Lipitor.

After four months of therapy, 91 percent of the patients saw their cholesterol drop below 100 mg/dl. Of these, 11 percent saw their cholesterol drop below 40 mg/dl, according to the report.

Compared with other groups, those with cholesterol levels of less than 40 mg/dl and those whose cholesterol was in the range of 40 to 60 mg/dl had fewer heart attacks, strokes, cardiac death, chest pain or additional heart procedures, the researchers found.
Moreover, there were no significant differences in adverse side effects from statins, such as muscle, liver or retinal abnormalities, bleeding in the brain or death.

"We can feel comfortable using high-dose statins in all high-risk patients, even if their cholesterol ends up at 40 mg/dl.
That's actually a good thing," Cannon says. "The message is that lower is better and safe."

One expert believes these results will lower current cholesterol goals.

"I think this is an important direction of our therapy for the future -- lowering the bar," says Dr. Eric J. Topol, chairman of the department of cardiovascular medicine and chief academic officer at The Cleveland Clinic. "And this study helps, validating its remarkable safety."